CEO Sharon Chen showcased AlphaLife Sciences' AuroraPrime platform at Johnson & Johnson Innovation JLABS Summits, emphasizing GenAI-powered advancements in medical writing and accelerating drug development through streamlined clinical documentation.
Alice Hsu presented AI-powered clinical trials at DIA 2024, while CEO Sharon Chen shared strategic insights on innovative approaches as a panel expert.
AlphaLife Sciences CEO Sharon Chen attended Microsoft Build: AI Day in Bangkok, engaging with CEOs and Satya Nadella on advancing AI and cloud technology.
AlphaPrime integrates its AuroraPrime platform with OpenAI, enhancing clinical research with ChatGPT and exploring AGI applications in drug development.